Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Account Payables (2019 - 2025)

Historic Change in Account Payables for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$2.9 million.

  • Korro Bio's Change in Account Payables fell 115240.17% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 21090.02%. This contributed to the annual value of -$1.3 million for FY2024, which is 14325.81% down from last year.
  • Korro Bio's Change in Account Payables amounted to -$2.9 million in Q3 2025, which was down 115240.17% from $1.1 million recorded in Q2 2025.
  • Korro Bio's 5-year Change in Account Payables high stood at $2.8 million for Q4 2023, and its period low was -$2.9 million during Q3 2025.
  • For the 5-year period, Korro Bio's Change in Account Payables averaged around -$23789.5, with its median value being -$202000.0 (2023).
  • Per our database at Business Quant, Korro Bio's Change in Account Payables skyrocketed by 112871.29% in 2024 and then tumbled by 115240.17% in 2025.
  • Korro Bio's Change in Account Payables (Quarter) stood at -$382000.0 in 2021, then surged by 439.27% to $1.3 million in 2022, then surged by 115.35% to $2.8 million in 2023, then crashed by 121.68% to -$605000.0 in 2024, then crashed by 374.05% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q3 2025, $1.1 million for Q2 2025, and $99000.0 during Q1 2025.